##plugins.themes.academic_pro.article.sidebar##

Download
pdf
Statistic
Read Counter : 23 Download : 35

##plugins.themes.academic_pro.article.main##

Abstract

To conduct a comprehensive analysis of modern aspects of enzymatic dysfunction in female infertility and to explore innovative methods for its correction

Keywords

innovative comprehensive modern

##plugins.themes.academic_pro.article.details##

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

How to Cite
Ernazarova S.I, & Shukurov F.I. (2024). Contemporary Perspectives On The Impact Of Enzymatic Dysfunction In The Pathogenesis Of Female Infertility And Innovative Approaches To Its Treatment (Literature Review). Texas Journal of Medical Science, 36, 1–12. https://doi.org/10.62480/tjms.2024.vol36.pp1-12
Crossref
Scopus
Google Scholar
Europe PMC

References

  1. Adamyan LV, Andreeva EN, Gasparyan SA. Polycystic ovary syndrome in reproductive age
  2. (modern approaches to diagnosis and treatment). Clinical guidelines (treatment protocol). Moscow.
  3. ;22. [Adamyan LV, Andreeva EN, Gasparyan SA. Sindrom polikistoznyx yaichnikov v
  4. reproduktivnom vozraste (sovremennye podxody k diagnostike i lecheniyu). Klinicheskie
  5. rekomendatsii (protokol lecheniya). Moskva. 2015;22.] [in Russian]
  6. Avrukeviсh EA. Morphological evaluation of the functional layer of the endometrium in women
  7. operated on for ovarian cystic formations. Smolenskiy Meditsinskiy Almanax. 2017;(1):13-17.
  8. [Avrukeviсh EA. Morfologicheskaya otsenka funktsionalnogo sloya endometriya jenshin,
  9. prooperirovannyx po povodu kistoznyx obrazovaniy yaichnikov. Smolenskiy Meditsinskiy
  10. Almanax. 2017;(1):13-17.] [in Russian]
  11. Azizova ME. Polycystic ovary syndrome from the perspective of modern concepts. Kazanskiy
  12. Meditsinskiy Zhurnal. 2015;(1):77-80. [Azizova ME. Sindrom polikistoznyx yaichnikov s pozitsiy
  13. sovremennyx predstavleniy. Kazanskiy Meditsinskiy Zhurnal. 2015;(1):77-80.] [in Russian]
  14. Atykanov AO, Januzakov NT, Batyrkhanov ShK. Clinical and diagnostic characteristics of
  15. polycystic ovary syndrome in women of reproductive age. Vestnik KRSU. 2017;17(7):75-81.
  16. [Atykanov AO, Januzakov NT, Batyrkhanov ShK. Kliniko-diagnosticheskaya xarakteristika
  17. sindroma polikistoznyx yaichnikov u jenshin reproduktivnogo vozrasta. Vestnik KRSU.
  18. ;17(7):75-81.] [in Russian]
  19. Roberts RM, Lowe J. Enzyme-catalyzed processes essential for fertilization in mammals: A
  20. review. Biology of Reproduction. 2014;90(3):42-45.
  21. Andreeva EN. The effect of folate-containing combined oral contraceptives on homocysteine
  22. levels in women with polycystic ovary syndrome. Problemy Reproduktsii. 2014;(2):27-31.
  23. [Andreeva EN. Vliyanie folatsoderjashhix kombinirovannyx oralnyx kontratseptivov na urovni
  24. gomosisteina u jenshin s sindromom polikistoznyx yaichnikov. Problemy Reproduktsii.
  25. ;(2):27-31.] [in Russian]7. Gasparov AS. Assessment of ovarian reserve in women with benign ovarian tumors after various
  26. types of surgical treatment. Kremlevskaya Meditsina. 2013;(1):100-105. [Gasparov AS. Otsenka
  27. ovariyalnogo rezerva yaichnikov s dobrokachestvennymi opuxolyami posle raznyx vidov
  28. xirurgicheskogo lecheniya. Kremlevskaya Meditsina. 2013;(1):100-105.] [in Russian]
  29. Grigoryan OR. Polycystic ovary syndrome - long-term risks. Effektivnaya Farmakoterapiya.
  30. Akusherstvo i Ginekologiya. 2015;1(5):20-25. [Grigoryan OR. Sindrom polikistoznyx yaichnikov
  31. – otdalennye riski. Effektivnaya Farmakoterapiya. Akusherstvo i Ginekologiya. 2015;1(5):20-25.]
  32. [in Russian]
  33. Davydov AI, Shaxlamova MN, Chaban OV, Pirogova MN. High surgical energies in operative
  34. gynecology. Voprosy Ginekologii, Akusherstva i Perinatologii. 2013;(5):75-85. [Davydov AI,
  35. Shaxlamova MN, Chaban OV, Pirogova MN. Vysokie xirurgicheskie energii v operativnoy
  36. ginekologii. Voprosy Ginekologii, Akusherstva i Perinatologii. 2013;(5):75-85.] [in Russian]
  37. Dovjenko TV, Ilyina NA, Grodnitskaya EE. The problem of mental disorders in polycystic ovary
  38. syndrome. Socialnaya i Klinicheskaya Psixiatriya. 2015;25(2):94-100. [Dovjenko TV, Ilyina NA,
  39. Grodnitskaya EE. Problema psihicheskix narusheniy pri sindrome polikistoznyx yaichnikov.
  40. Socialnaya i Klinicheskaya Psixiatriya. 2015;25(2):94-100.] [in Russian]
  41. Zaxidova KSh, Raximova GN. The problem of sclerocystic ovary syndrome in women of
  42. reproductive age. Problemy Biologii i Meditsiny. 2020;120(4):198-203. [Zaxidova KSh,
  43. Raximova GN. Problema sindroma sklerokistoznyx yaichnikov u jenshin reproduktivnogo perioda.
  44. Problemy Biologii i Meditsiny. 2020;120(4):198-203.] [in Russian]
  45. Al-Ruthia YS, Al-Mandeel H, AlSanawi H. Ovulation induction by metformin among obese versus
  46. non-obese women with polycystic ovary syndrome. Saudi Pharm J. 2017;25(5):795-800.
  47. Audebert A, Darai E, Benifla JL. Postoperative abdominal adhesions and their prevention in
  48. gynecological surgery: I. What should you know? Gynecol Obstet Fertil. 2012;40(6):365-370.
  49. Bhattacharya SM. Prevalence and risk of depressive disorders in women with polycystic ovary
  50. syndrome (PCOS). Fertil Steril. 2010;94(2):357-359.
  51. Chen X, Yang D, Mo Y. Prevalence of polycystic ovary syndrome in unselected women from
  52. southern China. Eur J Obstet Gynecol Reprod Biol. 2018;139:59-64.
  53. Sato M, Imai H, Hirabayashi M. The role of lysosomal enzymes in oocyte maturation and
  54. preimplantation development. J Reprod Dev. 2012;58(2):258-264.
  55. Dewailly D, Andersen CY, Balen A. The physiology and clinical utility of anti–Mullerian hormone
  56. in women. Hum Reprod Update. 2014;20(4):370-385.
  57. Dokras A, Clifton S, Futterweit W, Wild R. Increased prevalence of anxiety symptoms in women
  58. with polycystic ovary syndrome: systematic review and meta-analysis. Fertil Steril.
  59. ;97(2):225-230.
  60. Smith GD, Takayama S, Swain JE. Rethinking in vitro embryo culture: New developments in
  61. culture platforms and potential to improve assisted reproductive technologies. Biol Reprod.
  62. ;86(5):1-10.
  63. Escobar–Morreale HF, Luque–Ramirez M, Gonzalez F. Circulating inflammatory markers in
  64. polycystic ovary syndrome: a systematic review and meta-analysis. Fertil Steril. 2011;95(3):1048-
  65. Fauser BC, Tarlatzis BC. Frontiers in Gynecological Endocrinology: Volume 3: Ovarian Function
  66. and Reproduction – From Needs to Possibilities. Springer. 2015;207.
  67. Lizneva D, Diamond MP, Azziz R, Suturina L, Kirubakaran R, Mykhalchenko K, Chernukha G.
  68. Phenotypes and body mass in women with polycystic ovary syndrome identified in referral versus
  69. unselected populations: systematic review and meta-analysis. Fertil Steril. 2016;106(6):1510-
  70. Mitra S, Nayak PK, Agrawai S. Laparoscopic ovarian drilling: an alternative but not the ultimate
  71. in the management of polycystic ovary syndrome. J Nat Sci Biol Med. 2015;6(1):40-48.
  72. Zagrebelnaya IV. Modern aspects of the pathogenesis and treatment of endocrine infertility.
  73. Mejdunarodniy Meditsinskiy Zhurnal. 2010. [Zagrebelnaya IV. Sovremennye aspekty patogeneza
  74. i lecheniya endokrinogo besplodiya. Mejdunarodniy Meditsinskiy Zhurnal. 2010.] [in Russian]